Exercise-induced Erythropoiesis: the Mechnistic of Angiotensin II
Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
The major aims are to determine the effect of acute (single dose) blockade of ANGII receptor
1 (AT1) on the EPO response to a single session of endurance exercise, as well as determine
the effect of chronic (8-week) blockade of AT1 on ET-induced adaptations in total circulating
red blood volume and hemoglobin.